Early Access Treatment With Tralesinidase Alfa in Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B)

NCT07733856 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis Type IIIB
MPS IIIB (Sanfilippo B Syndrome)

Interventions

DRUG: Tralesinidase alfa (TA)

Sponsor

Spruce Biosciences